Merz Pharma Group

Merz has announced the start of localized production of its dementia drug in Russia in partnership with ZiO-Zdorovie (Pharmeco State Corporation).

16 February 2016
Moscow Region

Investor profile

Merz Pharma Group


Company's website:

T: +49-(0)69 - 15 03 - 0

Private company


Contact: Dr. Martin Zügel Ph.D., CEO

Merz Pharma Group is a private company with headquarters in Frankfurt (Germany) and multiple successful divisions in 20 countries around the world.

The company runs ambitious research projects, develops innovative products for aesthetic medicine and botulinum therapy (movement disorders therapy) and invests venture capital in the development of a global market for aesthetic dermatology.